Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Primary Aldosteronism
NCT06523465Phase 4Recruiting
- Sponsor
- Army Medical University
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of simvastatin in primary aldosteronism (PA) (3 arms), sponsored by Army Medical University. Primary endpoints: changes in plasma aldosterone levels at 6 months and changes in 24-hour urinary aldosterone levels at 6 months. Started Sep 2024; status: recruiting.
02
Drugs
simvastatin
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT06523465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06523465.